Amgen immunotherapies show positive results

You are here: Home > Biotech > Current Article

By Staff Report / Tuesday, December 4th, 2018 / Comments Off on Amgen immunotherapies show positive results

Amgen released positive data for two immunotherapies in its BiTE platform, treating acute myeloid leukemia and multiple myeloma, the latter of which has been fast-tracked for development by the U.S. Food and Drug Administration. The Thousand Oaks-based biotech giant announced Dec. 3 that its AMG 420 and AMG 330 immunotherapies had both shown early evidence…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.